Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor. This story matters for Finance & Markets readers tracking currency. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. CurrencyNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily currency signal